Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates

Oct. 7, 2010

Evotec and Shionogi form multiple-target drug discovery alliance

Oct. 6, 2010

DSP and SanBio develop new stem cell therapy for stroke

Oct. 6, 2010

Noven acquires Daytrana methylphenidate transdermal system from Shire

Oct. 6, 2010

Meda acquires erectile dysfunction therapy Muse from Vivus

Oct. 6, 2010

Brain Factory gains Japanese rights to Eisai's ravuconazole prodrug

Oct. 6, 2010

Lundbeck acquires exclusive rights to KW-6356 from Kyowa Hakko Kirin

Oct. 6, 2010

Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia

Oct. 5, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...